TOHETI aims to show how imaging technology can be used more effectively as a diagnostic and therapeutic tool across a range of common patient pathways.

Phase 1 of TOHETI focused on identifying pathways where changing the way imaging was used could see benefits from a patient outcome, experience and health economics perspective. Working with GPs, clinicians and imaging staff, models were developed to improve and revise pathways, taking into account the entire patient journey.

Pathways identified include breast, colon, prostate and lung cancers, persistent headache, acute chest pain, uterine fibroids and scaphoid fractures.

TOHETI also introduced the advanced technologies of PET-MR and MR-guided High Intensity Frequency Ultrasound to King’s Health Partners. By harnessing these cutting edge technologies, TOHETI aims to enable imaging potential to be fully realised for patient benefit, to help improve and personalise care.

During phase 2 (years 1-3), Pilots/trials across each of the pathways were implemented. In phase 2 , year 4, focus is on data analysis and implementation of pathways. Focus has been that projects must benefit patient experience, outcome and health economics across King’s Health Partners.